Todd Foley is a co-founder of Aktis Oncology and has served as Chair of its board of directors since August 2020. Since 1999 he has worked at MPM BioImpact, a biotechnology investment firm, where he is a Managing Director focused on venture investments in biotech companies, and he has served on the boards of Entrada Therapeutics, Repare Therapeutics, Rhythm Pharmaceuticals and Chiasma. He received a BS in Chemistry from the Massachusetts Institute of Technology and an MBA from Harvard Business School.